Cite
HARVARD Citation
Al Draiweesh, S. et al. (n.d.). A130 SAFETY OF COMBINATION BIOLOGIC AND ANTI-REJECTION THERAPY POST-LIVER TRANSPLANTATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: LONDON ONTARIO EXPERIENCE. Journal of the Canadian Association of Gastroenterology. pp. 260-261. [Online].